EIDOS THERAPEUTICS, INC. Earnings Per Share (Diluted)
EIDOS THERAPEUTICS, INC. reported Earnings Per Share (Diluted) of -$0.79 per share for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2020-09-30 was -$0.79, a 538.89% decline year-over-year.
- EIDOS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2020-06-30 was -$0.75.
- EIDOS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2020-03-31 was -$0.60.
- EIDOS THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2019-12-31 was -$0.51.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$0.79 10-Q · filed 2020-10-29 | -$1.53 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$2.14 10-Q · filed 2020-10-29 | -$2.61 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2020-06-30 | -$0.75 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.34 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$1.82 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.66 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2020-03-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.08 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$0.91 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.29 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2019-12-31 | -$0.51 10-K · filed 2020-02-26 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$0.69 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.02 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2019-09-30 | $0.18 10-Q · filed 2020-10-29 | -$0.19 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$0.52 10-Q · filed 2020-10-29 | -$0.76 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2019-06-30 | -$0.39 10-K · filed 2020-02-26 | -$0.70 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$0.95 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.24 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2019-03-31 | -$0.32 10-K · filed 2020-02-26 | -$0.57 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$0.86 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.44 derived: net income ÷ weighted average shares · filed 2020-10-29 |
| 2018-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.55 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.14 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$1.85 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-09-30 | -$0.30 10-Q · filed 2019-10-31 | -$0.98 derived: net income ÷ weighted average shares · filed 2019-10-31 | -$1.83 10-Q · filed 2019-10-31 | |
| 2018-06-30 | -$1.27 derived: net income ÷ weighted average shares · filed 2019-08-01 | -$2.86 derived: net income ÷ weighted average shares · filed 2019-08-01 | ||
| 2018-03-31 | -$1.71 derived: net income ÷ weighted average shares · filed 2019-05-07 | |||
| 2017-12-31 | -$2.76 derived: net income ÷ weighted average shares · filed 2020-02-26 | |||
| 2016-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2019-04-15 |